The Role of Caffeine in Noninvasive Respiratory Support

• Autores: Nicole R. Dobson, Ravi Mangal Patel
• Localización: Clinics in Perinatology, ISSN 0095-5108, Vol. 43, Nº. 4, 2016, págs. 773-782
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Caffeine is one of the most commonly prescribed medications in preterm neonates and is widely used to treat or prevent apnea of prematurity. Caffeine therapy is safe, effectively decreases apnea, and improves short- and long-term outcomes in preterm infants. In this review, the authors summarize the role of caffeine therapy for preterm infants receiving noninvasive respiratory support. As caffeine is already widely used, recent data are summarized that may guide clinicians in optimizing the use of caffeine therapy, with a review of the timing of initiation, dose, and duration of therapy.